tiprankstipranks
Company Announcements

FibroBiologics Raises Funds Through Strategic Equity Sales to GEM

Don't Miss our Black Friday Offers:

The latest announcement is out from FibroBiologics, Inc. (FBLG).

FibroBiologics, Inc. sold 100,000 shares to GEM at $4.51 each, after a 10% discount, totaling $451,000 in proceeds. This followed a previous transaction where 3 million shares facilitated a draw down, with GEM accepting 840,000 of these at $4.09 per share, providing FibroBiologics with $3.44 million in proceeds. The unutilized 1.5 million shares from the draw down notice will be returned and cancelled, with the Company having received a total of $3.89 million from its sales under the share purchase agreement with GEM.

For an in-depth examination of FBLG stock, go to TipRanks’ Stock Analysis page.

Related Articles
TheFlyFibroBiologics files patent application for cell-based therapeutic
TheFlyFibroBiologics files patent application on reduction of clots related to IBMIR
TipRanks Auto-Generated NewsdeskFibroBiologics Reports Q3 2024 Financial Results
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App